ADVFN ADVFN

Hot Features

Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
Amphastar Pharmaceuticals Inc

Amphastar Pharmaceuticals Inc (AMPH)

19,74
1,04
(5,56%)
Fermé 06 Juin 10:00PM
19,281
-0,459
(-2,33%)
Après les heures de négociation: 1:56AM

Amphastar Pharmaceuticals Inc (AMPH) Action

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Statistiques et détails clés

Dernier
19,281
( 3,11% )
Prix Achat
18,80
Prix Vente
22,50
Volume échangé
750 319
18,85 Fourchette du Jour 20,142
16,645 Plage de 52 semaines 31,2641
Cap du marché
Clôture Veille
18,70
Ouverture
18,86
Dernière Transaction
150
@
19.281
(formt)
Dernière heure de transaction
Volume financier
US$ 14 793 283
VWAP
19,716
Volume moyen (3 m)
US$ 621 109
Actions en circulation
44 092 919
Rendement du Dividende (LTM)
Ratio Cours sur Bénéfices
11,31
Bénéfice par action (BPA)
1,67
Chiffre d'affairess (LTM)
720,53M
Bénéfice net (LTM)
79,23M

À propos de Amphastar Pharmaceuticals Inc

Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. It offers BAQSIMI, a dry nasal spray used in an emergency for the treatment of se... Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. It offers BAQSIMI, a dry nasal spray used in an emergency for the treatment of severe hypoglycemia; Primatene MIST, an epinephrine inhalation product for the temporary relief of mild symptoms of intermittent asthma; Glucagon for injection emergency kit; Enoxaparin, an injectable form of low molecular weight heparin for the prevention and treatment of deep vein thrombosis; and REXTOVY and Naloxone for opioid overdose. The company also provides Cortrosyn, a lyophilized power for use as a diagnostic agent in the screening of patients with adrenocortical insufficiency; Amphadase, a bovine-sourced hyaluronidase injection; Epinephrine injection for allergic reactions; Lidocaine jelly, an anesthetic product for urological procedures; Lidocaine topical solution for various procedures; Phytonadione injection, a vitamin K1 injection for newborn babies; and emergency syringe products, including atropine, calcium chloride, dextrose, epinephrine, lidocaine, and sodium bicarbonate. In addition, it offers Albuterol sulfate inhalation aerosol for the treatment or prevention of bronchospasm; Iron sucrose injection, an iron replacement product for the treatment of iron deficiency anemia in patients with chronic kidney disease; Teriparatide injection for managing daily osteoporosis therapy; and Ipratropium Bromide HFA inhalation aerosol, an anticholinergic indicated for the maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease. Further, the company provides active pharmaceutical ingredient (API) products, such as Recombinant Human Insulin and porcine insulin API. The company was founded in 1996 and is headquartered in Rancho Cucamonga, California. Show more

Secteur
Healthcare
Industrie
Pharmaceuticals
Siège social
Rancho Cucamonga, United States
Fondé
1996
Amphastar Pharmaceuticals Inc est coté dans le secteur Healthcare de la NASDAQ avec le ticker AMPH. Le dernier cours de clôture d'Amphastar Pharmaceuticals était de US$18,70. Au cours de la dernière année, les actions de Amphastar Pharmaceuticals ont été négociées dans une fourchette de prix de US$ 16,645 à US$ 31,2641.

Amphastar Pharmaceuticals compte actuellement 44 092 919 actions en circulation. La capitalisation boursière d'Amphastar Pharmaceuticals est de US$850,16 million. Amphastar Pharmaceuticals a un ratio cours/bénéfice (ratio PE) de 11.31.

AMPH Dernières nouvelles

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10.0009999999999980.0051867219916919.2819.8517.7363955118.53419851CS
40.2811.478947368421919.8516.64587062218.26163214CS
121.0615.8232711306318.2224.34516.64559560219.54186528CS
26-7.869-28.983425414427.1529.5216.64551120421.98780872CS
52-6.619-25.55598455625.931.264116.64549613523.8139997CS
156-27.419-58.713062098546.767.6616.64547291936.41081616CS
2600.5512.9418045915618.7367.6616.64541124834.80224073CS

AMPH - Frequently Asked Questions (FAQ)

What is the current Amphastar Pharmaceuticals Inc share price?
The current share price of Amphastar Pharmaceuticals Inc is US$ 19,281
How many Amphastar Pharmaceuticals Inc shares are in issue?
Amphastar Pharmaceuticals Inc has 44 092 919 shares in issue
What is the market cap of Amphastar Pharmaceuticals Inc?
The market capitalisation of Amphastar Pharmaceuticals Inc is USD 850,16M
What is the 1 year trading range for Amphastar Pharmaceuticals Inc share price?
Amphastar Pharmaceuticals Inc has traded in the range of US$ 16,645 to US$ 31,2641 during the past year
What is the PE ratio of Amphastar Pharmaceuticals Inc?
The price to earnings ratio of Amphastar Pharmaceuticals Inc is 11,31
What is the cash to sales ratio of Amphastar Pharmaceuticals Inc?
The cash to sales ratio of Amphastar Pharmaceuticals Inc is 1,15
What is the registered address of Amphastar Pharmaceuticals Inc?
The registered address for Amphastar Pharmaceuticals Inc is 11570 6th Street, Rancho Cucamonga, California, 91730
What is the Amphastar Pharmaceuticals Inc website address?
The website address for Amphastar Pharmaceuticals Inc is www.amphastar.com
Which industry sector does Amphastar Pharmaceuticals Inc operate in?
Amphastar Pharmaceuticals Inc operates in the Pharmaceuticals sector

AMPH Transactions

Plus

Transactions différées

Pour obtenir des transactions en temps réel, améliorez votre compte

Passer à la version en temps réel
Aucune Discussion Trouvée
Ajouter une Discussion